Objective. To audit appropriate use of blood products in adult patients.
The inappropriate use of medical technology is a major factor There is a need for continuous audit of the use of blood products as therapy, mainly in hospitals where there is no transin increased health care expenses; inappropriate use of blood fusion committee, as in the Ciudad Hospitalaria 'Dr. Enrique is costly. These elevated expenses are caused by the need to Tejera'. This paper reports the results of a cross-sectional study guarantee safety of the transfusion [1] [2] [3] and to avoid high designed to determine the rate of appropriate use of transhealth risk [4] [5] [6] [7] [8] . In a study about factors affecting the cost of fusions in different departments of this health care facility. transfusion of blood products, Koistinen pointed out four
Of course, these results may provide a good opportunity for items: the costs of collection, laboratory costs, handling costs, improvements and to find strategies for such improvements. and blood administration costs [3] . Furthermore, there is a risk of transfusion-transmitted disease, mainly those associated with retroviruses and hepatitis viruses [4] ; however, in South America there is the additional risk of transfusion-associated Materials and methods transmission of trypanosomes and malaria. Therefore, inappropriate use of transfusion may cause additional costs for This study was conducted at the 'Ciudad Hospitalaria Dr. Enrique Tejera' in Valencia, Venezuela, a hospital of 900 beds and treatment of these diseases.
centre of reference for a population of 3 million in the North and 17% received three or more transfusions. Of the patients, 165 were from Medicine, 218 from Surgery, 144 from EmerCentral Region of Venezuela. The study included patients aged 12 years or older from the Surgery, Medicine, Emergency and gency and 173 from Obstetrics.
The overall prevalence of appropriate use was 51.3% for all Obstetrics departments. We analysed 700 consecutive requests for transfusions in a 6-month period starting in February 1997. departments. Appropriateness of the use of blood products by department is shown in Table 1 . The mean number of A total of 1700 transfusions were evaluated in these 700 patients (1 unit of blood product was considered as one transfusion).
transfusions by department was found to be statistically significant (Medicine, 3.41±3.48; Surgery, 1.75±0.94; Emer-A review of the patient's medical history was done on each request for a blood product. This review was carefully carried gency, 2.81±2.7; Obstetrics, 2.09±0.85; P<0.0000). No associations were found between the inappropriate use rate out by two of the authors (GC and GP). Even though all reviewers were using the same methods and criteria, if any and either sex or age (P<0. 26 and P<0.40, respectively) .
CI for the odds of inappropriate use of blood products by discrepancy occurred, one of us (AM, the haematologist) made the final decision. The patient records were analysed for the department show statistically significant differences (Emergency, 1.38, 95%CI=0.81-2.34; Obstetrics, 2.79, 95%CI= following factors: age, sex, current diagnosis, department, type and amount of blood products, and the reasons or stated in-1.73-4.49; Surgery, 4.40, 95%CI=2.70-7.00). The department of Medicine was used as the reference group. CI for the odds dication for the transfusion of a blood product. When information was not available or was unclear, the patient was not of inappropriate use of each blood product are shown in Table  2 . included in the study. When the reasons for the transfusion were not clear, we considered the transfusion inappropriate. Since only information available on the medical charts was reviewed to determine the appropriateness of the transfusion, Discussion we did not attempt to evaluate the efficacy of the transfusion therapy.
This audit of transfusions determined that use of blood prodAppropriate use of blood products was assessed by using ucts was appropriate in 51% of cases. Studies similar to this are the criteria established by Audet and Goodnough for packed unknown in Latin America. red cells (PRC) [9] , by the British Committee for Standards in Each blood product will be discussed separately given the Haematology for fresh frozen plasma (FFP) [10] , by the NIH variety of reasons for transfusing red blood cells, FFP, platelets Consensus Conference for platelets [11] and by the College of and cryoprecipitate. American Pathologists for cryoprecipitate [12] .
Inappropriate use of a blood product for a particular subject Packed red blood cells was considered as a violation of the established criteria shown above.
As in Mozes et al. [13] and Schot and Steenssens [14] the blood Given a wide variety of definitions of what is an appropriate products with greatest prevalence of inadequate use were PRC rate for the use of blood products, in this paper we define a and FFP. In an evaluation of red blood cell transfusion practices 'good' rate as any rate [80%.
with the use of pre-set criteria, Ghali et al. [15] found that in 55.3% of cases, PRC was transfused unnecessarily. In our study, 589 patients were transfused with PRC. Of Analysis of data these patients 27.84% (164/589) were transfused with a single All data were assembled into a database. Mean rates of ap-unit of PRC, and of these 164 patients, 61% (100/164) belonged propriate use ±SD were calculated. A 2 test was used to test to the group of inappropriate use. Metz et al.
[16] also found a associations between categorical variables as appropriate. For high proportion of inappropriate use of single-unit transfusion. continuous variables, the t-test statistic was used to test the Transfusion of a single unit of PRC should not be considered difference between two group means, and ANOVA was used inappropriate by itself; however, its use without an appropriate to compare groups for differences in the means of the trans-clinical judgement is not acceptable. Preference for immediate fusion by department. A logistic regression method was used alleviation of symptoms over prevention of later possible comto analyse the association of inappropriateness of transfusion plications has been postulated as one of the causes of this with related factors. The 'appropriate transfusion' was con-phenomenon [13] . Our explanation for such a limited apsidered as the dependent variable, and the independent vari-propriate use of blood component therapy seems to be: ables were age, sex and department. P values and confidence (i) absence of a transfusion committee in our hospital and, intervals (CI) are reported.
(ii) use of the laboratory criterion alone. In many instances a low haematocrit count is used to determine a request for a transfusion of PRC; the correct approach is to combine the laboratory criteria with the symptoms of the patient.
Results
Unfortunately, this Venezuelan hospital has no oversight programme for monitoring quality of transfusion practices, Transfusions were evaluated in 700 (54% female), mean age 39.51±18.58 years (95% CI=38.13-40.89). These patients which may be one reason for having such a low rate of appropriate use of transfusions. Grindon et al.
[17] point out that received 1700 transfusions (2.45±2.29 transfusions per patient); 59% received two transfusions, 24% received one, the presence of a transfusion committee assures consultation According to pre-set criteria, this study showed overall a high prevalence of appropriate use of platelets. However, as two in haemotherapy: it evaluates effectiveness of transfusion pracdepartments (Surgery and Obstetrics) showed a very low rate tices and corrects ineffective practices with blood products.
of appropriate use, the odds of transfusing platelets inFrom a general point of view, a decision to transfuse should appropriately is >1. The main indication for platelets transalways be based on an analysis of risk and benefit, and should fusion was to prevent bleeding in patients with marrow failure. consider two factors: (i) evaluation of the physiological needs There is a hypothesis that, regardless of the weight of the of the patient; and (ii) transfusing only blood products that recipient, transfusion of over 2 platelet units would be excessive satisfy those physiological needs [18] . As in the Metz series [24] . When deciding to transfuse platelets, physicians must [16], we found that many inappropriate transfusions of PRC consider other known factors that increase the risk of bleeding were carried out on asymptomatic patients in the perioperative in patients with thrombocytopaenia [25] and might suggest period, although there is no evidence that mild or moderate reduction in the use of platelets. Recently, Ancliff and Machin anaemia contributes to perioperative morbidity and mortality [26] reviewed data about the threshold for prophylactic platelet [19] [20] . In our research, inappropriate transfusion rates were transfusion and pointed out that a threshold of 10×10 9 /l is found not to be associated with age. According to the presafe in stable patients. However, according to Contreras [27] established criteria, transfusions of PRC in our patients with there is a need to define precise indications for use of platelet chronic renal failure were appropriate, but from the point transfusion, and this can be achieved by conducting ranof view of the relationship between risk and benefit, domized trials and effective and efficient audit. Therefore, we erythropoietin should have been used to manage the anaemia could ask ourselves what is truly an appropriate use of blood in these patients.
products? Until we get a precise definition of this, it will remain controversial.
Fresh frozen plasma
Many authors [13-14,16] also found in their studies a greater Cryoprecipitate prevalence of inadequate use of FFP. In our series, in no case was a prior determination made of a patient's coagulation de-We found a very high risk of receiving inappropriate transfusion of cryoprecipitate. The possible reasons for this high risk are ficiency in order to decide on the use of FFP. In addition, despite the fact that there is no evidence to justify the use of the same as those described for PRC, FFP and platelets. This blood product is indicated for use only in certain illnesses (see FFP as a volume expander, we found this misindication. This reflects little knowledge about the rational use of this blood Appendix).
Our results showed that the Surgery, Emergency and Obproduct, as FFP has risks and there are precise indications for its use [21] . This blood product must be used only as a source stetrics departments are associated with a higher risk of inappropriate transfusion than the Medicine department. In of clotting factors or plasma proteins. Drastic reduction in the use of total blood has been reported as the origin of in-contrast, Mozes et al. [13] reported no relationship between inappropriate transfusion and the Surgery, Medicine and Paeappropriate use of FFP [22] . A coagulation deficiency determination must be performed before requesting FFP. Once diatrics departments. It should be pointed out that our study Second, the department of Medicine has a postgraduate medical 6. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP.
school whereas the others departments do not. experience greater benefits despite the fact that high use is 9. Audet AM, Goodnough LT. Practice strategies for elective red more costly and despite the risk of adverse reactions [30] . of medical audit [31] [32] and continuing medical education 11. NIH Consensus Conference. Platelets transfusion therapy. J Am [33] [34] [35] [36] [37] . At the time of writing this paper, we are designing an 
